In vivo pharmacokinetics and metabolism of anti-human immunodeficiency virus agent d4T-5′-[p-bromophenyl methoxyalaninyl phosphate] (sampidine) in mice

Drug Metabolism and Disposition

Volumn 29, Issue 7, 2001, Pages 1035-1041

  Chen, Chun Lin ^a   Venkatachalam, T K ^a   Zhu, Zhao Hai ^a   Uckun, Fatih M ^a  

^a PARKER HUGHES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HI 113; NUCLEOSIDE DERIVATIVE; SAMPIDINE; STAVUDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYCYTIDINE MONOPHOSPHATE; FEMALE; MICE; MICE, INBRED BALB C; THIONUCLEOTIDES;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034962198     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Multiple forms of esterase in vertebrate blood plasma
2. Antiretrovirus specificity and intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine (Stavudine) and its 5′-monophosphate triester prodrug So324
3. Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives
4. Quantitative high-performance liquid chromatography based detection method for calphostin C, a naturally occurring perlenequinone with potent antileukemic activity
5. Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-genistein in patients with B-lineage lymphoid malignancies
6. A quantitative HPLC detection method for pharmacokinetic studies of the potent mast cell inhibitor 4-(4′-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131)
7. Pharmacokinetics and biological activity of the novel mast cell inhibitor, 4-(3′-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in mice
8. A quantitative HPLC detection method for WHI-P154 [4-(3′-bromo-4′hydroxylphenyl)-amino-6,7-dimethoxyquinazoline]
9. Pharmacokinetic features and metabolism of calphostin C, a naturally occurring perylenequinone with potent antileukemic activity
10. Physiological parameters in laboratory animals and humans
11. Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex
12. Drug metabolite concentration-time profiles: Influence of route of drug administration
13. Stavudine, a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection
14. Variability in the determination of fraction metabolized in a triangular metabollic problem and its resolution with stable isotope methodology
15. Metabolic deesterification of tazarotene in human blood and rat and human liver microsomes
16. 1-(2,3-Dideoxy-β-D-glycero-pent-2-enofuranosyl)thymine (d4T). A highly potent and selective anti-HIV agent
17. Table VII. Percentage points of the F distribution, α=0.05
18. Human xenobiotic metabolizing esterases in liver and blood
19. Metabolite pharmacokinetics: The area under the curve of metabolite and the fractional ate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites
20. Metabolite pharmacokinetics: Method for simultaneous estimates of elimination rate constants of a drug and its metabolite. A commentary
21. Dimethyl sulfoxide: Its steroid solubility and endocrinologic and pharmacologic-toxicologic characteristics
22. Disposition in animals of a new anti-HIV agent: 2′,3′-didehydro-3′deoxythymidine
23. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine
24. Pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus (HIV)-1
25. In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 [(4′hydroxylphenyl)-amino-6,7-dimethoxyquinazoline]
26. Enhanced effects of a mono-bromo substitution at the para position of the phenyl moiety on the metabolism and anti-HIV activity of D4T-phenyl methoxyalaninyl phosphate derivatives
27. D4T-5′-[p-bromophenyl methoxyalaninyl phosphate] as a potent and non-toxic anti-human immunodeficiency virus agent
28. A toxicological study of dimethyl sulfoxide